1. Home
  2. DRRX vs INM Comparison

DRRX vs INM Comparison

Compare DRRX & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRRX
  • INM
  • Stock Information
  • Founded
  • DRRX 1998
  • INM 1981
  • Country
  • DRRX United States
  • INM Canada
  • Employees
  • DRRX N/A
  • INM N/A
  • Industry
  • DRRX Biotechnology: Pharmaceutical Preparations
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • DRRX Health Care
  • INM Health Care
  • Exchange
  • DRRX Nasdaq
  • INM Nasdaq
  • Market Cap
  • DRRX N/A
  • INM 3.2M
  • IPO Year
  • DRRX 2000
  • INM N/A
  • Fundamental
  • Price
  • DRRX $0.61
  • INM $3.01
  • Analyst Decision
  • DRRX Hold
  • INM
  • Analyst Count
  • DRRX 1
  • INM 0
  • Target Price
  • DRRX N/A
  • INM N/A
  • AVG Volume (30 Days)
  • DRRX 65.1K
  • INM 55.3K
  • Earning Date
  • DRRX 05-12-2025
  • INM 05-13-2025
  • Dividend Yield
  • DRRX N/A
  • INM N/A
  • EPS Growth
  • DRRX N/A
  • INM N/A
  • EPS
  • DRRX N/A
  • INM N/A
  • Revenue
  • DRRX $2,031,000.00
  • INM $4,832,013.00
  • Revenue This Year
  • DRRX N/A
  • INM N/A
  • Revenue Next Year
  • DRRX $935.93
  • INM N/A
  • P/E Ratio
  • DRRX N/A
  • INM N/A
  • Revenue Growth
  • DRRX N/A
  • INM N/A
  • 52 Week Low
  • DRRX $0.67
  • INM $1.72
  • 52 Week High
  • DRRX $1.88
  • INM $15.70
  • Technical
  • Relative Strength Index (RSI)
  • DRRX 26.58
  • INM 61.77
  • Support Level
  • DRRX $0.79
  • INM $2.56
  • Resistance Level
  • DRRX $0.72
  • INM $3.15
  • Average True Range (ATR)
  • DRRX 0.06
  • INM 0.27
  • MACD
  • DRRX -0.01
  • INM 0.08
  • Stochastic Oscillator
  • DRRX 20.93
  • INM 87.83

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: